Diagnos (TSXV:ADK) Stock Based Compensation : C$0.15 Mil (TTM As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Diagnos Stock Based Compensation?

Diagnos's Stock Based Compensation for the three months ended in Sep. 2024 was C$0.03 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.15 Mil.

Diagnos Stock Based Compensation Historical Data

The historical data trend for Diagnos's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnos Stock Based Compensation Chart

Diagnos Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Stock Based Compensation

Get a 7-Day Free Trial

0.13

0.25

0.43

0.17

0.18

Diagnos Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Stock Based Compensation	Get a 7-Day Free Trial															0.04	0.04	0.05	0.03	0.03

Diagnos Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.15 Mil.

Diagnos Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Diagnos's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagnos Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnos Inc (TSXV:ADK) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

DGNOF:USA

Address

7005 Taschereau Boulevard, Suite 265, Brossard, Longueuil, QC, CAN, J4Z 1A7

Website

http://www.diagnos.ca

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, Mexico, Chile, and others. The company's key revenue is derived from Canada.

Executives

Tristram Coffin	10% Security Holder
Marc-andré Massue	Senior Officer
Robert Dunn	Director
Francis Bellido	Director
Vincent Duhamel	Director
André Larente	Director, Senior Officer
Guillermo Moreno Robles	Senior Officer
Georges Hébert	Director
Gestion Maurice Pinsonnault Inc.	10% Security Holder

Diagnos Headlines

No Headlines